Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

REMS Integration Into Electronic Medical Records Mulled By FDA

This article was originally published in The Pink Sheet Daily

Executive Summary

Public meeting in October will solicit comments on how to further reduce the burdens of the drug safety programs.


Related Content

FDA Simplifies The Process For REMS Changes
REMS And Generics: GPhA Needs Legislation, Continues Education
FDAAA Fading? REMS Use Continues To Decline As Drug Safety Law Matures
REMS Communications Need FDA Logo To Boost Doctors’ Attention, Advisors Say
Buying Time: Industry Sacrifices Early To Gain Later With PDUFA V Review Model